EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 151 filers reported holding EXELIXIS INC in Q4 2015. The put-call ratio across all filers is 0.66 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $7,489,000 | -25.3% | 306,300 | -32.3% | 0.84% | +6.2% |
| Q1 2018 | $10,026,000 | +33.8% | 452,659 | +83.6% | 0.79% | +64.0% |
| Q4 2017 | $7,494,000 | +209.3% | 246,519 | +146.5% | 0.48% | +205.7% |
| Q3 2017 | $2,423,000 | -84.6% | 100,000 | -91.9% | 0.16% | -78.1% |
| Q3 2016 | $15,763,000 | +99.0% | 1,232,457 | +21.5% | 0.72% | +65.6% |
| Q2 2016 | $7,920,000 | +171.5% | 1,014,130 | +39.1% | 0.44% | +172.5% |
| Q1 2016 | $2,917,000 | -4.1% | 729,130 | +35.2% | 0.16% | +8.1% |
| Q4 2015 | $3,041,000 | -41.1% | 539,130 | -41.4% | 0.15% | -40.6% |
| Q3 2015 | $5,161,000 | – | 920,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 16,484,638 | $501,133,000 | 64.50% |
| Matrix Capital Management Company, LP | 10,000,000 | $304,000,000 | 10.86% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 410,334 | $12,470,000 | 4.40% |
| Rhenman & Partners Asset Management AB | 756,214 | $22,989,000 | 3.11% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 703,049 | $21,372,000 | 1.57% |
| Virtus ETF Advisers LLC | 36,522 | $1,110,000 | 1.39% |
| PURA VIDA INVESTMENTS, LLC | 80,000 | $2,432,000 | 1.02% |
| Crawford Lake Capital Management, LLC | 129,300 | $3,931,000 | 0.93% |
| SMITH ASSET MANAGEMENT GROUP LP | 865,880 | $26,323,000 | 0.83% |
| Crawford Lake Capital Management, LLC | 113,311 | $3,445,000 | 0.81% |